RT Journal Article
SR Electronic
T1 The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.21.21253498
DO 10.1101/2021.03.21.21253498
A1 Elisa Teyssou
A1 Cathia Soulie
A1 Benoit Visseaux
A1 Sidonie Lambert-Niclot
A1 Valentine Ferre
A1 Stéphane Marot
A1 Aude Jary
A1 Sophie Sayon
A1 Karen Zafilaza
A1 Valentin Leducq
A1 Aurélie Schnuriger
A1 Marc Wirden
A1 Nadhira Houhou-Fidouh
A1 Charlotte Charpentier
A1 Laurence Morand-Joubert
A1 Sonia Burrel
A1 Diane Descamps
A1 Vincent Calvez
A1 Anne Geneviève Marcelin
YR 2021
UL http://medrxiv.org/content/early/2021/03/26/2021.03.21.21253498.abstract
AB The 501Y.V2 and the 501Y.V1 SARS-CoV-2 variants emerged and spread rapidly into the world. We analysed the RT-PCR cycle threshold values of 643 nasopharyngeal samples of COVID-19 patients at diagnosis and found that the 501Y.V2 variant presented an intermediate viral load between the 501Y.V1 and the historical variants.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The CNIL (National Commission for Informatics and Freedoms) has authorized APHP (Assistance Publique - Hopitaux de Paris) to implement an automated processing of personal data to setting up the health data warehouse (EDS). This authorization allow the possibility of using the EDS to conduct non-interventional research on data in a scope beyond the care team, for which the use was already covered by a normal declaration. In APHP, all patients have been informed at their entrance by doctors that theirs data could be used for researche purposes except if they do not give their consent. This information is also reminding in the result report given to the patient. CNIL referent for AP-Sorbonne univiersity : Patrick Lefebvre All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall the data in this manuscript are available. The data are presented on an excel format. Contact to obtaine data: elisa.teyssou{at}aphp.fr